B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GRM5

MOLECULAR TARGET

glutamate metabotropic receptor 5

UniProt: P41594NCBI Gene: 29158 compounds

GRM5 (glutamate metabotropic receptor 5) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GRM5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1quisqualate3.0921
2Glutamic Acid2.9418
3Glutamic Acid2.9418
4fenobam anhydrous2.6413
5bdb whuutdbjxjrkmk2.208
6Ibotenic Acid0.691
7bdb 2 amino bicyclo 2 1 1 hexane 2 5 dicarboxylic acid abhxd i chembl905010.691
8bdb chembl24183640.691

About GRM5 as a Drug Target

GRM5 (glutamate metabotropic receptor 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented GRM5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GRM5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.